Turnover
≈ €160,000 estimated
The micro format states no turnover.
Dr. Roxanne Devadder
Lifetime
1 annual account with figurespeak €69,075 (2025)
€69,075
peak €47,239 (2025)
€47,239
peak €52,239 (2025)
€52,239
€11,378
Board1 name since 2025
1 directorDEVADDER Roxanne Marie Kristel
Documentsfilings and deeds
02-07-202629 days before the deadline
2025micro format
Incorporation 21-011 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€5,000 100 shares
Checked score
98
Excellent
Financially stronger than 82% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
02-2026: 0.3%
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.4%▲ +0.1 percentage points vs 06-2026highest value
08-2026: < 0.1%▼ -0.4 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 5.51, cash €42,322
Equity €52,239 (82.1% of total assets)
Figures for financial year 2025 (filed on 02-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 84% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as Dr. Roxanne Devadder has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of Dr. Roxanne Devadder itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for Dr. Roxanne Devadder. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.51, above the usual 1.5. Short-term debt is 15.8% and cash 66.5% of total assets. 17.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
29 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1018883644
Incorporation
Founding capital of €5,000, 100 shares · Founder: DEVADDER Roxanne Marie Kristel · Appointment: DEVADDER Roxanne Marie Kristel (director) · published on 21-01-2025 · Gazette deed
First establishment
Eugène Demolderlaan 95, Schaerbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Roxanne Devadder Schaerbeek | €63,617 | €69,075 | 82.1% | - |
| HB Expertise Brussels | €68,997 | €65,445 | 78.4% | - |
| Dr. Margaux Vanderstraeten Merchtem | €66,573 | €70,566 | 85.0% | - |
| DOKTER BINA PAUWELS Bornem | €69,250 | €72,149 | 79.9% | - |
| DOCTEUR MUSIN MARGAUX Beloeil | €65,763 | €65,923 | 65.4% | - |
| Dokter Vandewynckel Bruges | €71,153 | €67,606 | 79.4% | - |
| DS MED Genappe | €65,847 | €64,299 | 96.9% | - |
These companies have the same main activity as Dr. Roxanne Devadder: general medical practice (NACE 86210). They are comparable in size and age: total assets between €65,800 and €71,200, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 17-01-2025Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Establishment unit
- 2.369.237.7671030 Schaerbeek, since 17-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 01-09-2025
Annual accounts 2025
- €63,617
- Filing
- Filed on 02-07-2026, 29 days before the end of the filing period
Insights on Dr. Roxanne Devadder
Dr. Roxanne Devadder has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €52,239 and a net result of €47,239.
Its solvency ranks better than 73% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Roxanne Devadder
- What is the company number of Dr. Roxanne Devadder?
- The company number of Dr. Roxanne Devadder is 1018.883.644. The VAT number is the same number with BE in front: BE 1018.883.644.
- Where is Dr. Roxanne Devadder based?
- The registered office is at Eugène Demolderlaan 95, 1030 Schaerbeek.Company details
- What does Dr. Roxanne Devadder do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Dr. Roxanne Devadder?
- Dr. Roxanne Devadder is a private limited company (BV).
- When was Dr. Roxanne Devadder founded?
- Dr. Roxanne Devadder was founded on 17-01-2025.
- Is Dr. Roxanne Devadder still active?
- Yes, Dr. Roxanne Devadder is an active enterprise in the KBO register.
- What is the turnover of Dr. Roxanne Devadder?
- The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €69,075 and 32 comparable companies (NACE 862). It probably lies between €120,000 and €200,000.Financials
- Is Dr. Roxanne Devadder profitable?
- In financial year 2025, Dr. Roxanne Devadder made a profit of €47,239.
- Where can I find the annual accounts of Dr. Roxanne Devadder?
- Dr. Roxanne Devadder filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.